This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
British Journal of Cancer Open Access 28 September 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Haffty BG and Lannin D (2004) Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option? Eur J Cancer 40: 1105–1108
Haffty BG et al. (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359: 1471–1477
Seynaeve C et al. (2004) Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 40: 1150–1158
Robson ME et al. (2004) A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6: R8–R17
Brekelmans CT et al. (2006) Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17: 391–400
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Robson, M. Is breast conservation a reasonable option for women with BRCA-associated breast cancer?. Nat Rev Clin Oncol 4, 10–11 (2007). https://doi.org/10.1038/ncponc0687
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0687
This article is cited by
-
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
British Journal of Cancer (2010)